The world journal of men's health · 2019
Herbal Phytotherapy in Chronic Nonbacterial Prostatitis.
Редакционная статьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Park Min Jung, Park Hyun Jun, Cheon Won Hee, Park Jih Hoon, Shin Byung Cheul, Park Nam Cheol
Аннотация
OBJECTIVE: This study analyzed postoperative radiation therapy outcomes in women with International Federation of Gynecology and Obstetrics stage I clear cell and papillary serous endometrial carcinomas to inform treatment decisions.
METHODS: Surveillance, Epidemiology, and End Results data (2000-2016) was analyzed for females with localized endometrial clear cell or papillary serous carcinoma. The Fine-Gray subdistribution hazard model with competing risks analysis evaluated the effect of age, histology, and radiation modality on the cumulative incidence of death from endometrial cancer. Gray's test compared survival outcomes between external beam radiation therapy (EBRT), combination of EBRT with brachytherapy, and brachytherapy.
RESULTS: Four hundred forty-six patients were included. Mean diagnosis age was 67.92 years. Age was a significant covariate, with a 2% increased risk of death per additional year. Overall survival at 5 and 10 years was 80.87% and 77.94%, respectively. EBRT and brachytherapy were almost equally utilized; combination therapy was less common. At least 60.26% of patients treated with brachytherapy received systemic therapy, compared to 26.92% with EBRT and 12.82% with combination therapy. Brachytherapy showed superior survival outcomes compared to EBRT, with hazard ratios of 0.44 (95% confidence interval [CI]=0.26-0.74; p=0.002) for 5-year and 0.40 (95% CI=0.21-0.77; p=0.006) for 10-year outcomes. Cumulative incidence of death from cancer differed significantly between radiation modalities.
CONCLUSION: Patients predominantly received a single radiation modality. Brachytherapy was associated with superior survival outcomes and systemic therapy use, though patient selection factors may contribute to this finding. Increasing age was associated with a higher risk of death.
METHODS: Surveillance, Epidemiology, and End Results data (2000-2016) was analyzed for females with localized endometrial clear cell or papillary serous carcinoma. The Fine-Gray subdistribution hazard model with competing risks analysis evaluated the effect of age, histology, and radiation modality on the cumulative incidence of death from endometrial cancer. Gray's test compared survival outcomes between external beam radiation therapy (EBRT), combination of EBRT with brachytherapy, and brachytherapy.
RESULTS: Four hundred forty-six patients were included. Mean diagnosis age was 67.92 years. Age was a significant covariate, with a 2% increased risk of death per additional year. Overall survival at 5 and 10 years was 80.87% and 77.94%, respectively. EBRT and brachytherapy were almost equally utilized; combination therapy was less common. At least 60.26% of patients treated with brachytherapy received systemic therapy, compared to 26.92% with EBRT and 12.82% with combination therapy. Brachytherapy showed superior survival outcomes compared to EBRT, with hazard ratios of 0.44 (95% confidence interval [CI]=0.26-0.74; p=0.002) for 5-year and 0.40 (95% CI=0.21-0.77; p=0.006) for 10-year outcomes. Cumulative incidence of death from cancer differed significantly between radiation modalities.
CONCLUSION: Patients predominantly received a single radiation modality. Brachytherapy was associated with superior survival outcomes and systemic therapy use, though patient selection factors may contribute to this finding. Increasing age was associated with a higher risk of death.